• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测米兰标准内肝细胞癌肝切除术后无病生存期的验证列线图:个体化监测策略

Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.

作者信息

Ma Ka Wing, She Wong Hoi, Cheung Tan To, Chan Albert Chi Yan, Dai Wing Chiu, Fung James Yan Yue, Lo Chung Mau, Chok Kenneth Siu Ho

机构信息

Divisions of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong, China.

Department of Medicine, The University of Hong Kong, 102 Pokfulam Road, Hong Kong, China.

出版信息

Surg Today. 2019 Jun;49(6):521-528. doi: 10.1007/s00595-019-1764-x. Epub 2019 Jan 14.

DOI:10.1007/s00595-019-1764-x
PMID:30637484
Abstract

OBJECTIVE

We sought to develop a nomogram for the prediction of tumor recurrence after resection of hepatocellular carcinoma (HCC) within the Milan criteria.

METHOD

Consecutive HCC patients admitted for hepatectomy between 1994 and 2014 were enrolled in this study. Patients were excluded if they had recurrent HCC or tumors beyond the Milan criteria. Patients were randomized and assigned to the derivation and validation sets in a 1:1 ratio. Independent factors for disease-free survival were identified using the Cox regression model. A nomogram was derived and validated with the receiver-operating characteristic (ROC) and calibration curves.

RESULTS

There were 617 eligible patients included in the analysis. The median age was 59 years, 481 were male, and 87.8% of the patients were hepatitis B virus carriers. The median follow-up was 68.7 months. The 5-year overall survival rate was 73.3% and HCC recurrence was detected in 55% of the patients. In the derivation set, a nomogram was constructed based on the seven independent factors for disease-free survival: age, alpha-fetoprotein, preoperative prothrombin time, magnitude of hepatectomy, postoperative complication, number of tumor nodules, and presence of microvascular invasion. A satisfactory discrimination ability was observed in both the derivation and validation sets (c-stat 0.672 and 0.665, respectively). The calibration plot yielded agreement between the predicted and observed outcomes, using the derived nomogram.

CONCLUSION

A validated nomogram quantifies the risk of recurrence after hepatectomy for HCC within the Milan criteria, and assists with the planning of individual postoperative surveillance protocols.

摘要

目的

我们试图开发一种列线图,用于预测米兰标准内肝细胞癌(HCC)切除术后的肿瘤复发情况。

方法

本研究纳入了1994年至2014年间因肝切除术入院的连续HCC患者。如果患者有复发性HCC或肿瘤超出米兰标准,则将其排除。患者按1:1的比例随机分配到推导集和验证集。使用Cox回归模型确定无病生存的独立因素。通过受试者操作特征(ROC)曲线和校准曲线推导并验证列线图。

结果

分析纳入了617例符合条件的患者。中位年龄为59岁,481例为男性,87.8%的患者为乙型肝炎病毒携带者。中位随访时间为68.7个月。5年总生存率为73.3%,55%的患者检测到HCC复发。在推导集中,基于无病生存的七个独立因素构建了列线图:年龄、甲胎蛋白、术前凝血酶原时间、肝切除量、术后并发症、肿瘤结节数量和微血管侵犯情况。在推导集和验证集中均观察到了良好的区分能力(c统计量分别为0.672和0.665)。使用推导的列线图,校准图显示预测结果与观察结果之间具有一致性。

结论

经过验证的列线图可量化米兰标准内HCC肝切除术后的复发风险,并有助于制定个体化的术后监测方案。

相似文献

1
Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy.用于预测米兰标准内肝细胞癌肝切除术后无病生存期的验证列线图:个体化监测策略
Surg Today. 2019 Jun;49(6):521-528. doi: 10.1007/s00595-019-1764-x. Epub 2019 Jan 14.
2
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
3
Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study.对于超出米兰标准的肝细胞癌患者,手术切除优于经动脉化疗栓塞术:一项预后列线图研究
Ann Surg Oncol. 2016 Mar;23(3):994-1002. doi: 10.1245/s10434-015-4929-x. Epub 2015 Oct 20.
4
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.基于微血管侵犯的新型预后列线图预测肝细胞癌R0切除术后患者的生存结局
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
5
Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.基于血小板相关模型的简化列线图用于预测亚洲肝细胞癌患者术后的生存情况。
Surg Oncol. 2019 Sep;30:131-138. doi: 10.1016/j.suronc.2019.07.008. Epub 2019 Jul 22.
6
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.基于影像组学的Nomogram 模型预测肝癌患者肝切除术后的总生存情况
Cancer Imaging. 2020 Nov 16;20(1):82. doi: 10.1186/s40644-020-00360-9.
7
[The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].基于Ishak炎症评分的列线图对肝细胞癌根治性切除术后复发的研究
Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):124-129. doi: 10.3760/cma.j.issn.0529-5815.2018.02.009.
8
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.腹腔镜肝切除术后预测肝细胞癌复发的列线图。
Cancer Commun (Lond). 2019 Oct 11;39(1):55. doi: 10.1186/s40880-019-0404-6.
9
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发:对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
10
Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.列线图预测肝癌术后单发肿瘤患者的个体生存情况。
Gut Liver. 2017 Sep 15;11(5):684-692. doi: 10.5009/gnl16465.

引用本文的文献

1
The prognostic role of an optimal machine learning model based on clinical available indicators in HCC patients.基于临床可用指标的最佳机器学习模型在肝癌患者中的预后作用。
Front Med (Lausanne). 2024 Jul 17;11:1431578. doi: 10.3389/fmed.2024.1431578. eCollection 2024.
2
A new method for predicting the microvascular invasion status of hepatocellular carcinoma through neural network analysis.通过神经网络分析预测肝细胞癌微血管侵犯状态的新方法。
BMC Surg. 2023 Apr 28;23(1):100. doi: 10.1186/s12893-023-01967-y.
3
Treatments for recurrent hepatocellular carcinoma: laparoscopic or open repeat liver resection, how to make a decision?

本文引用的文献

1
Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.高龄对接受肝细胞癌切除术患者生存的影响:一项日本全国性调查的报告。
Ann Surg. 2019 Apr;269(4):692-699. doi: 10.1097/SLA.0000000000002526.
2
Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.米兰标准以外的肝细胞癌切除术后复发预测:一项国际队列临床风险评分的验证
Ann Surg. 2017 Oct;266(4):693-701. doi: 10.1097/SLA.0000000000002360.
3
Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration.
复发性肝细胞癌的治疗:腹腔镜还是开放再次肝切除术,如何抉择?
Updates Surg. 2023 Jun;75(4):1045-1046. doi: 10.1007/s13304-023-01503-w. Epub 2023 Apr 20.
4
Treatments for the Early-Stage Hepatocellular Carcinoma: Laparoscopic Liver Resection or Percutaneous Radiofrequency: How to Make a Decision?早期肝细胞癌的治疗:腹腔镜肝切除术还是经皮射频消融:如何抉择?
Liver Cancer. 2021 Nov 24;11(2):178-179. doi: 10.1159/000521136. eCollection 2022 Apr.
5
Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China.建立用于预测中国南方TP53基因249位丝氨酸突变的乙型肝炎相关肝细胞癌患者短期无病生存的预后模型。
Transl Cancer Res. 2020 Aug;9(8):4517-4533. doi: 10.21037/tcr-19-2788.
6
A Novel Nomogram to Predict Prolonged Survival After Hepatectomy in Repeat Recurrent Hepatocellular Carcinoma.一种预测复发性肝细胞癌肝切除术后长期生存的新型列线图。
Front Oncol. 2021 Mar 25;11:646638. doi: 10.3389/fonc.2021.646638. eCollection 2021.
7
15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma.基于 15-lncRNA 的分类器-临床病理列线图改善了肝细胞癌患者复发的预测。
Dis Markers. 2020 Dec 1;2020:9180732. doi: 10.1155/2020/9180732. eCollection 2020.
8
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.新型模型预测乙型肝炎病毒相关≤10cm 单发肝细胞癌且无门静脉癌栓患者的术后复发和总生存期。
Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6.
局限性肝细胞癌的手术切除:患者选择及特殊考量
J Hepatocell Carcinoma. 2016 Dec 28;4:1-9. doi: 10.2147/JHC.S96085. eCollection 2017.
4
Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.无肉眼可见血管侵犯的孤立性肝细胞癌的解剖性切除与非解剖性切除:一项倾向评分匹配分析
J Gastroenterol Hepatol. 2017 Apr;32(4):870-878. doi: 10.1111/jgh.13603.
5
A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.一种新型且经过验证的基于炎症的评分(IBS)可预测肝细胞癌患者根治性手术切除后的生存率:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2016 Feb;95(7):e2784. doi: 10.1097/MD.0000000000002784.
6
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?早期肝细胞癌的挽救性肝移植与原位肝移植:两种策略的结果相似吗?
Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442.
7
Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection.术后并发症影响肝细胞癌根治性切除术后的早期复发。
BMC Cancer. 2015 Oct 14;15:689. doi: 10.1186/s12885-015-1720-0.
8
A three-factor preoperative scoring model predicts risk of recurrence after liver resection or transplantation in hepatocellular carcinoma patients with preserved liver function.一种三因素术前评分模型可预测肝功能保留的肝细胞癌患者肝切除或肝移植术后的复发风险。
Hepatobiliary Pancreat Dis Int. 2015 Oct;14(5):477-84. doi: 10.1016/s1499-3872(15)60412-x.
9
Scoring system based on tumor markers and Child-Pugh classification for HCC patients who underwent liver resection.基于肿瘤标志物和Child-Pugh分级的肝切除术后肝癌患者评分系统。
Anticancer Res. 2015 Apr;35(4):2157-63.
10
Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysis.老年肝细胞癌患者的治疗效果不受影响:一项倾向评分分析。
Medicine (Baltimore). 2014 Dec;93(28):e264. doi: 10.1097/MD.0000000000000264.